Bridged and fused heterocyclic antidiabetic compounds

Details for Australian Patent Application No. 2010206786 (hide)

Owner Schering Corporation

Inventors Josien, Hubert B.; Clader, John W.; Greenlee, William J.; Mayer, Michael John; Herr, Robert Jason; Davis, Jason L.; Deng, Kai; Hsia, Ming Min; Wan, Shuangyi

Agent Spruson & Ferguson

Pub. Number AU-A-2010206786

PCT Pub. Number WO2010/085525

Priority 61/146,879 23.01.09 US

Filing date 21 January 2010

Wipo publication date 29 July 2010

International Classifications

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

C07D 215/233 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 217/24 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/085525 Priority application(s): WO2010/085525

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010206789-Bridged and fused antidiabetic compounds

2010206783-Pentafluorosulpholane-containing antidiabetic compounds